Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigational Study of Riluzole Effects on Hippocampus Biomarkers

NCT04630444 is registered in ClinicalTrials.gov with Mclean Hospital as lead sponsor.

NCT NCT04630444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04630444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigational Study of Riluzole Effects on Hippocampus Biomarkers
Lead sponsor
Mclean Hospital
Phase
Phase 1
Overall status
Completed
Start date
March 16, 2017
Completion date
March 16, 2019
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

posttraumatic stress disorder